Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine, the active ingredient in Milgamma, is a vitamin supplement presented as an oral dosage form for oral use. It is combined with pyridoxine hydrochloride (vitamin B6) to support carbohydrate metabolism and nerve function in adults, helping to reduce advanced glycation end‑products and assist amino‑acid metabolism.

GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Milgamma, a combined benfotiamine and pyridoxine supplement, is used in conditions related to carbohydrate metabolism and nerve health.

- Diabetic peripheral neuropathy: helps reduce nerve pain and improve sensory function. - Metabolic support in diabetes: assists in lowering formation of advanced glycation end‑products. - Vitamin B6 deficiency: contributes to normal amino‑acid metabolism and hemoglobin formation.

Milgamma is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset reported by some users. - Headache: transient headache may appear. - Skin rash: mild, localized erythema. - Dizziness: occasional light‑headedness. - Gastrointestinal discomfort: mild abdominal cramping.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic enzyme elevation: rare increase in liver function tests. - Hematologic abnormalities: rare cases of blood dyscrasias. - Severe cutaneous reactions: such as Stevens‑Johnson syndrome. - Peripheral neuropathy worsening: very uncommon exacerbation of existing neuropathy.

Before using Milgamma, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if clearly needed and advised by a clinician. - Renal impairment: monitor kidney function and adjust use if required. - Hepatic impairment: exercise caution and monitor liver enzymes. - Concomitant medications: review all current drugs for potential interactions. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Milgamma may interact with other medicines; awareness of the type of interaction helps manage risk.

Major Interactions (Avoid): - Anticonvulsants (e.g., phenobarbital): may increase metabolism, reducing efficacy. - High‑dose vitamin B6 supplements: risk of cumulative toxicity. - Chemotherapy agents (e.g., vincristine): may exacerbate neurotoxicity.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: may enhance glucose‑lowering effect, requiring dose adjustment. - Warfarin: pyridoxine can affect INR, necessitating closer monitoring. - Alcohol: concurrent use may increase risk of neuropathy or liver stress.